chr11-5226799-C-A
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PM5PP3
The NM_000518.5(HBB):c.93G>T(p.Arg31Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000138 in 1,613,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin Lovd. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R31G) has been classified as Pathogenic.
Frequency
Consequence
NM_000518.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.93G>T | p.Arg31Ser | missense_variant, splice_region_variant | 2/3 | ENST00000335295.4 | NP_000509.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.93G>T | p.Arg31Ser | missense_variant, splice_region_variant | 2/3 | 1 | NM_000518.5 | ENSP00000333994 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000346 AC: 87AN: 251316Hom.: 0 AF XY: 0.000280 AC XY: 38AN XY: 135804
GnomAD4 exome AF: 0.000126 AC: 184AN: 1461592Hom.: 0 Cov.: 36 AF XY: 0.000107 AC XY: 78AN XY: 727138
GnomAD4 genome AF: 0.000250 AC: 38AN: 152270Hom.: 0 Cov.: 32 AF XY: 0.000389 AC XY: 29AN XY: 74464
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 02, 2022 | The Hb Tacoma variant (HBB: c.93G>T; p.Arg31Ser, also known as Arg30Ser when numbered from the mature protein, HbVar ID: 289, rs1135071) is reported in the literature in the heterozygous state in individuals with mild anemia or no symptoms (Deacon-Smith 1978, Idelson 1974, Landin 1993), and in one individual with Hb S who had sickle cell trait (Honig 1980). This variant is also reported in ClinVar (Variation ID: 15368) and is found in the Finnish European population with an allele frequency of 0.36% (90/25120 alleles) in the Genome Aggregation Database. The arginine at codon 31 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.947). This variant is the first nucleotide of the exon, and computational analyses (Alamut v.2.11) predict that this variant may impact splicing by weakening the nearby canonical acceptor splice site. Functional analyses demonstrate a normal oxygen affinity but slight instability (Deacon-Smith 1978, Honig 1980). Due to conflicting information, the clinical significance of the Hb Tacoma variant is uncertain at this time. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Deacon-Smith RA and Lee-Potter JP. An unstable haemoglobin, Hb Tacoma beta30 (B12) arg leads to ser, detected at birth by the demonstration of red cell inclusions. J Clin Pathol. 1978 Sep;31(9):883-7. PMID: 711920. Honig GR et al. Two new sickle cell syndromes: HbS, Hb Camden, and alpha-thalassemia; and HbS in combination with Hb Tacoma. Blood. 1980 Apr;55(4):655-60. PMID: 7357091. Idelson LI et al. New unstable haemoglobin (Hb Moscva, beta24 (B4) Gly leads to Asp) found in the USSR. Nature. 1974 Jun 21;249(459):768-70. PMID: 4525423. Landin B and Jeppsson JO. Rare beta chain hemoglobin variants found in Swedish patients during HBA1c analysis. Hemoglobin. 1993 Aug;17(4):303-18. PMID: 8226093. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jun 18, 2023 | The HBB c.93G>T (p.Arg31Ser) variant (also known as Hb Tacoma) has been reported to have normal oxygen affinity but slightly reduced stability (PMIDs: 31553106 (2020), 7357091 (1980), 5785231 (1969), 5869485 (1965)). Individuals who are heterozygous for this variant have normal presentations (PMID: 5869485 (1965)) or mild anemia (PMIDs: 34233561 (2021), 8226093 (1993), 3937827 (1985)). Co-occurrence of this variant with Hb S presented as clinically healthy (PMID: 7357091 (1980)), but in combination with a beta(+)-thalassemia variant resulted in moderate microcytic anemia (PMID: 10975446 (2000)). Additionally, an individual who was compound heterozygous for Hb Tacoma caused by a different nucleotide change (c.93G>C, p.Arg31Ser) and a HBB pathogenic variant associated with beta(0)-thalassemia is reported to have transfusion-dependent beta thalassemia (PMID: 9140720 (1997)). Analysis of this variant using bioinformatics tools indicates that the effect of this variant's amino acid change on protein structure and function is damaging, and it may also affect proper HBB mRNA splicing. Clinical correlation and genetic counseling are recommended. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 21, 2018 | This sequence change replaces arginine with serine at codon 31 of the HBB protein (p.Arg31Ser). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and serine. This variant is present in population databases (rs1135071, ExAC 0.3%). This variant has been observed in individuals and families with elevated Hb A2 levels, but most individuals are either clinically unaffected or experience only mild anemia (PMID: 8226093, 4525423, 5869485, 3937827, 7357091). This variant is also known as Arg30Ser and Hb Tacoma in the literature. ClinVar contains an entry for this variant (Variation ID: 15368). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Pathogenic:1Uncertain:1
Pathogenic, flagged submission | literature only | OMIM | Feb 01, 2002 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 30, 2024 | Variant summary: HBB c.93G>T (p.Arg31Ser) results in a non-conservative amino acid change located in the Globin domain (IPR000971) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. Computational tools predict a significant impact on normal splicing: Three predict the variant weakens a canonical 3' acceptor site. One predicts the variant has no significant impact on splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00035 in 251316 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in HBB causing Beta Thalassemia (0.00035 vs 0.011), allowing no conclusion about variant significance. Hb Tacoma is used to describe the substitution of Arg-to-Ser at codon 31 (legacy codon 30) and can be due to either c.93G>T or c.93G>C. It has been reported in the literature in heterozygous individuals with no clinical or hematological abnormalities apart from mild anemia (Deacon-Smith_1978, Harano_1985, Moore_2021) and in one heterozygous individual who also carried Hb S and had normal hematological findings (Honig_1980). c.93G>T in particular was reported in heterozygous individuals with normal hematological findings in some of them and slight hemolytic anemia in others, while importantly it was also reported in a 12-year-old boy in compound heterozygosity with pathogenic variant c.93-21G>A and no signs of disease (Landin 1993, 2000). The variant was also found in multiuple homozygous individuals without clinical information (Kangastupa_2023). These reports do not provide unequivocal conclusions about association of the variant with Beta Thalassemia. Experimental evidence evaluating an impact on protein function demonstrate the variant to display in vitro instability, including a decreased alkaline Bohr effect and haem-haem interaction but normal oxygen affinity (Deacon-Smith_1978, Hayashi_1974). These data do not allow convincing conclusions about the variant effect The following publications have been ascertained in the context of this evaluation (PMID: 8226093, 6859036, 7357091, 711920, 3937827, 4407364, 10975446, 34233561, 36633442). ClinVar contains an entry for this variant (Variation ID: 15368). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Heinz body anemia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2002 | - - |
beta Thalassemia Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 16, 2021 | - - |
Beta-thalassemia HBB/LCRB Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Nov 26, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at